Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 7;103(6):1840-5.
doi: 10.1073/pnas.0509228103. Epub 2006 Jan 30.

Nod1-dependent control of tumor growth

Affiliations

Nod1-dependent control of tumor growth

Jean da Silva Correia et al. Proc Natl Acad Sci U S A. .

Abstract

Nod1, a cytosolic protein that senses meso-diaminopimelic acid-containing ligands derived from peptidoglycan, plays a role in host responses to invasive bacteria. Here we describe a function for Nod1, whereby it controls tumor formation. Cell lines derived from the human breast cancer epithelial cell line MCF-7 were used in a severe combined immune deficiency (SCID) mouse xenograft model to characterize a pathway linking Nod1 to the growth of estrogen-sensitive tumors. In MCF-7 cells, the absence of Nod1 correlates with tumor growth, an increased sensitivity to estrogen-induced cell proliferation, and a failure to undergo Nod1-dependent apoptosis. Conversely, overexpression of Nod1 in MCF-7 cells results in inhibition of estrogen-dependent tumor growth and reduction of estrogen-induced proliferative responses in vitro.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: No conflicts declared.

Figures

Fig. 1.
Fig. 1.
Nod1 is involved in TNFα-induced apoptosis and triggers an apoptotic cascade. (a) Nod1 protein is absent in MCF-7 C20 cells. Cell extracts from MCF-7 parental and MCF-7 C20 cells were either immunoprecipitated with a monoclonal anti-Nod1 antibody or directly loaded on SDS/PAGE and analyzed by immunoblotting by using anti-Nod1 antibody. (b) MCF-7 C20 cells are more resistant to TNFα-induced apoptosis than parental cells. MCF-7 parental and MCF-7 C20 cells were treated with TNFα (10 ng/ml), and cell viability was determined by PI-exclusion assay and flow cytometry analysis. Data are expressed as mean ± SD of four independent experiments. (c) Morphological changes in γTriDAP-treated MCF-7 Nod1 cells. Cells were treated with γTriDAP/CHX (2, 4, 6) or CHX alone (1, 3, 5) and stained with DAPI (3, 4) or TUNEL (5, 6), fixed, and observed under a fluorescence microscope. (d) γTriDAP-induced apoptosis is abolished by broad-spectrum caspase inhibitors. MCF-7 Nod1 cells were pretreated with Z-VAD-Fmk or Boc-D-Fmk inhibitors (50 μM each) before addition of γTriDAP/CHX, and cell viability was measured.
Fig. 2.
Fig. 2.
Nod1 mediates γTriDAP-induced cell death. MCF-7 Blasto, MCF-7 Nod1, MCF-7 C20, and MCF-7 C20/Nod1 cells were treated with γTriDAP or αTriDAP (20 μg/ml each) in the presence or absence of CHX (3 μg/ml). Cell viability was measured by flow cytometry analysis. Data are expressed as mean ± SD of four independent experiments.
Fig. 3.
Fig. 3.
Synergic activation of apoptosis by γTriDAP and TNFα in SK-BR3 cells. SKBR3 Nod1 cells were treated with various combinations of TNFα (T), γTriDAP (γ), αTriDAP (α), and CHX (C). Cells were harvested 18 h posttreatment and analyzed for cell viability by PI staining and flow cytometry (Upper). Data are expressed as mean ± SD of six independent experiments. Cell extracts were also prepared and subjected to immunoblotting with specific antibodies recognizing proforms and cleaved fragments of PARP and caspases 3, 7, and 8. Results show a representative experiment from three independent experiments.
Fig. 4.
Fig. 4.
Nod2 does not induce apoptosis in MCF-7 cells. MCF-7 Blasto, MCF-7 Nod1, and MCF-7 Nod2 were treated with γTriDAP or MDP (20 μg/ml each) in the presence or absence of CHX. (a) Cell death was measured by flow cytometry. (b) Cell supernatants were harvested and assayed for IL-8 secretion. Data are expressed as mean ± SD of three independent experiments. (c) Expression of Nod1 and Nod2 was confirmed by Western blot analysis by using anti-Myc antibody.
Fig. 5.
Fig. 5.
The presence of Nod1 prevents tumor growth in SCID mice. (a) MCF-7 Blasto, MCF-7 C20, and MCF-7 C20/Nod1 cells (3 × 106 cells per mouse) were injected in the flanks of female SCID mice. Tumor size was measured once a week, and volume was determined according to the formula (W2 × L)/2. Each line represents tumor growth of 1 mouse (n = 4). (b) Mice were implanted with estrogen pellets before injection with MCF-7 cells, and tumor size was determined. Mean ± SD are shown for 8 mice. (c) MCF-7 C20 and MCF-7 RIP2ΔCARD cells show a higher sensitivity to estrogens. Indicated MCF-7 cells were exposed to increasing concentration of 17β-estradiol and pulsed with [3H]thymidine, and cell growth was determined by liquid scintillation. Data are representative of at least three independent experiments. (d) Down-regulation of endogenous ERα by Nod1. Total protein extracts from MCF-7 Blasto, MCF-7 C20, and MCF-7 C20/Nod1 cells and from cells isolated from tumors were analyzed by immunoblotting by using antibody against ERα and ERK2 as loading control.

References

    1. Janeway C. A., Jr, Medzhitov R. Annu. Rev. Immunol. 2002;20:197–216. - PubMed
    1. Beutler B. Mol. Immunol. 2004;40:845–859. - PubMed
    1. Ting J. P., Davis B. K. Annu. Rev. Immunol. 2005;23:387–414. - PubMed
    1. Inohara N., Ogura Y., Chen F. F., Muto A., Nunez G. J. Biol. Chem. 2001;276:2551–2554. - PubMed
    1. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., et al. J. Biol. Chem. 2003;278:5509–5512. - PubMed

Publication types

Substances

LinkOut - more resources